Trials / Not Yet Recruiting
Not Yet RecruitingNCT06992349
Bioptron Light Therapy for Dysmenorrhea in Obese Adolesences: RCT
Evaluating the Efficacy of Bioptron° Light Therapy in Managing Primary Dysmenorrhea Among Obese Adolescence: Double Blinded Randomized Control Trial
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 144 (estimated)
- Sponsor
- Alaa Noureldeen Kora · Academic / Other
- Sex
- Female
- Age
- 16 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
Dysmenorrhea is the most common health problem in women in the reproductive age(Bakhsh et al., 2022). The primary dysmenorrhea starts shortly after the menarche the pain lasting 1 to 3 days that start just before or at the onset of menstruation with the absence of other gynecological symptoms (Itani et al., 2022). Primary dysmenorrhea can reduce the quality of life and social activities of women(Esan et al., 2024). There is a relationship between body mass composition and primary dysmenorrhea and as the value of body mass index and body fat percentages goes on increasing in females, the severity of primary dysmenorrhea also increased (Wu et al., 2022). BIOPTRON® Light therapy system is a device that contains an optical unit. This unit emits light with an electromagnetic spectrum produced by the sun, but without the ultraviolet rays and it is significant with four main characteristics which are Polarization, Polychromatic, Incoherence and low energy light (Raeissadat et al., 2014). The Purpose of the Study The aim of the study is to investigate the effect of bioptron© light therapy on primary dysmenorrhoea outcomes as pain and quality of life among obese adolescence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | bioptron light therapy | BIOPTRON® Hyperlight is a proprietary, optimized blend of visible and infrared light properties that Bio-stimulate cells and speeding up the healing process of a wide range of medical diseases. Bioptron© light therapy has been utilized as a non-invasive treatment for wound healing, skin ulcers, and various musculoskeletal conditions(Abd Elhamid et al., 2020). |
Timeline
- Start date
- 2025-08-01
- Primary completion
- 2025-08-31
- Completion
- 2025-08-31
- First posted
- 2025-05-28
- Last updated
- 2025-05-28
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06992349. Inclusion in this directory is not an endorsement.